
According to this study, over the next five years the Therapeutic Protein market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Therapeutic Protein business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Protein market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Therapeutic Protein, covering the supply chain analysis, impact assessment to the Therapeutic Protein market size growth rate in several scenarios, and the measures to be undertaken by Therapeutic Protein companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Monoclonal Antibodies
Erythropoietin
Insulin
Interferon
Human Growth Hormone
Follicle Stimulating Hormone
Blood Clotting Factors
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Pharmaceutical Companies
Healthcare Service Providers
Research Organizations
Academic Research Institutes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen
Generex Biotechnology
Abbott Laboratories
Baxter International
Boehringer Ingelheim
AstraZeneca
Eli Lilly
Chugai Pharmaceutical
GeneScience Pharmaceuticals
Diasome Pharmaceuticals
Genentech
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Therapeutic Protein consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Therapeutic Protein market by identifying its various subsegments.
Focuses on the key global Therapeutic Protein manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Therapeutic Protein with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Therapeutic Protein submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Therapeutic Protein Consumption 2015-2025
2.1.2 Therapeutic Protein Consumption CAGR by Region
2.2 Therapeutic Protein Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Erythropoietin
2.2.3 Insulin
2.2.4 Interferon
2.2.5 Human Growth Hormone
2.2.6 Follicle Stimulating Hormone
2.2.7 Blood Clotting Factors
2.3 Therapeutic Protein Consumption by Type
2.3.1 Global Therapeutic Protein Consumption Market Share by Type (2015-2020)
2.3.2 Global Therapeutic Protein Revenue and Market Share by Type (2015-2020)
2.3.3 Global Therapeutic Protein Sale Price by Type (2015-2020)
2.4 Therapeutic Protein Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Healthcare Service Providers
2.4.3 Research Organizations
2.4.4 Academic Research Institutes
2.5 Therapeutic Protein Consumption by Application
2.5.1 Global Therapeutic Protein Consumption Market Share by Type (2015-2020)
2.5.2 Global Therapeutic Protein Value and Market Share by Type (2015-2020)
2.5.3 Global Therapeutic Protein Sale Price by Type (2015-2020)
3 Global Therapeutic Protein by Company
3.1 Global Therapeutic Protein Sales Market Share by Company
3.1.1 Global Therapeutic Protein Sales by Company (2018-2020)
3.1.2 Global Therapeutic Protein Sales Market Share by Company (2018-2020)
3.2 Global Therapeutic Protein Revenue Market Share by Company
3.2.1 Global Therapeutic Protein Revenue by Company (2018-2020)
3.2.2 Global Therapeutic Protein Revenue Market Share by Company (2018-2020)
3.3 Global Therapeutic Protein Sale Price by Company
3.4 Global Therapeutic Protein Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Therapeutic Protein Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Therapeutic Protein Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Therapeutic Protein by Regions
4.1 Therapeutic Protein by Regions
4.2 Americas Therapeutic Protein Consumption Growth
4.3 APAC Therapeutic Protein Consumption Growth
4.4 Europe Therapeutic Protein Consumption Growth
4.5 Middle East & Africa Therapeutic Protein Consumption Growth
5 Americas
5.1 Americas Therapeutic Protein Consumption by Countries
5.1.1 Americas Therapeutic Protein Consumption by Countries (2015-2020)
5.1.2 Americas Therapeutic Protein Value by Countries (2015-2020)
5.2 Americas Therapeutic Protein Consumption by Type
5.3 Americas Therapeutic Protein Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Therapeutic Protein Consumption by Regions
6.1.1 APAC Therapeutic Protein Consumption by Regions (2015-2020)
6.1.2 APAC Therapeutic Protein Value by Regions (2015-2020)
6.2 APAC Therapeutic Protein Consumption by Type
6.3 APAC Therapeutic Protein Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Therapeutic Protein by Countries
7.1.1 Europe Therapeutic Protein Consumption by Countries (2015-2020)
7.1.2 Europe Therapeutic Protein Value by Countries (2015-2020)
7.2 Europe Therapeutic Protein Consumption by Type
7.3 Europe Therapeutic Protein Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Therapeutic Protein by Countries
8.1.1 Middle East & Africa Therapeutic Protein Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Therapeutic Protein Value by Countries (2015-2020)
8.2 Middle East & Africa Therapeutic Protein Consumption by Type
8.3 Middle East & Africa Therapeutic Protein Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Therapeutic Protein Distributors
10.3 Therapeutic Protein Customer
11 Global Therapeutic Protein Market Forecast
11.1 Global Therapeutic Protein Consumption Forecast (2021-2025)
11.2 Global Therapeutic Protein Forecast by Regions
11.2.1 Global Therapeutic Protein Forecast by Regions (2021-2025)
11.2.2 Global Therapeutic Protein Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Therapeutic Protein Forecast by Type
11.8 Global Therapeutic Protein Forecast by Application
12 Key Players Analysis
12.1 Amgen
12.1.1 Company Information
12.1.2 Therapeutic Protein Product Offered
12.1.3 Amgen Therapeutic Protein Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Amgen Latest Developments
12.2 Generex Biotechnology
12.2.1 Company Information
12.2.2 Therapeutic Protein Product Offered
12.2.3 Generex Biotechnology Therapeutic Protein Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Generex Biotechnology Latest Developments
12.3 Abbott Laboratories
12.3.1 Company Information
12.3.2 Therapeutic Protein Product Offered
12.3.3 Abbott Laboratories Therapeutic Protein Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Abbott Laboratories Latest Developments
12.4 Baxter International
12.4.1 Company Information
12.4.2 Therapeutic Protein Product Offered
12.4.3 Baxter International Therapeutic Protein Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Baxter International Latest Developments
12.5 Boehringer Ingelheim
12.5.1 Company Information
12.5.2 Therapeutic Protein Product Offered
12.5.3 Boehringer Ingelheim Therapeutic Protein Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Boehringer Ingelheim Latest Developments
12.6 AstraZeneca
12.6.1 Company Information
12.6.2 Therapeutic Protein Product Offered
12.6.3 AstraZeneca Therapeutic Protein Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 AstraZeneca Latest Developments
12.7 Eli Lilly
12.7.1 Company Information
12.7.2 Therapeutic Protein Product Offered
12.7.3 Eli Lilly Therapeutic Protein Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Eli Lilly Latest Developments
12.8 Chugai Pharmaceutical
12.8.1 Company Information
12.8.2 Therapeutic Protein Product Offered
12.8.3 Chugai Pharmaceutical Therapeutic Protein Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Chugai Pharmaceutical Latest Developments
12.9 GeneScience Pharmaceuticals
12.9.1 Company Information
12.9.2 Therapeutic Protein Product Offered
12.9.3 GeneScience Pharmaceuticals Therapeutic Protein Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 GeneScience Pharmaceuticals Latest Developments
12.10 Diasome Pharmaceuticals
12.10.1 Company Information
12.10.2 Therapeutic Protein Product Offered
12.10.3 Diasome Pharmaceuticals Therapeutic Protein Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Diasome Pharmaceuticals Latest Developments
12.11 Genentech
12.11.1 Company Information
12.11.2 Therapeutic Protein Product Offered
12.11.3 Genentech Therapeutic Protein Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Genentech Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Therapeutic Protein Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Monoclonal Antibodies
Table 5. Major Players of Erythropoietin
Table 6. Major Players of Insulin
Table 7. Major Players of Interferon
Table 8. Major Players of Human Growth Hormone
Table 9. Major Players of Follicle Stimulating Hormone
Table 10. Major Players of Blood Clotting Factors
Table 11. Global Consumption Sales by Type (2015-2020)
Table 12. Global Therapeutic Protein Consumption Market Share by Type (2015-2020)
Table 13. Global Therapeutic Protein Revenue by Type (2015-2020) ($ million)
Table 14. Global Therapeutic Protein Value Market Share by Type (2015-2020) ($ Millions)
Table 15. Global Therapeutic Protein Sale Price by Type (2015-2020)
Table 16. Global Consumption Sales by Application (2015-2020)
Table 17. Global Therapeutic Protein Consumption Market Share by Application (2015-2020)
Table 18. Global Therapeutic Protein Value by Application (2015-2020)
Table 19. Global Therapeutic Protein Value Market Share by Application (2015-2020)
Table 20. Global Therapeutic Protein Sale Price by Application (2015-2020)
Table 21. Global Therapeutic Protein Sales by Company (2017-2019) (K MT)
Table 22. Global Therapeutic Protein Sales Market Share by Company (2017-2019)
Table 23. Global Therapeutic Protein Revenue by Company (2017-2019) ($ Millions)
Table 24. Global Therapeutic Protein Revenue Market Share by Company (2017-2019)
Table 25. Global Therapeutic Protein Sale Price by Company (2017-2019)
Table 26. Global Therapeutic Protein Manufacturing Base Distribution and Sales Area by Manufacturers
Table 27. Players Therapeutic Protein Products Offered
Table 28. Therapeutic Protein Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 29. Global Therapeutic Protein Consumption by Regions 2015-2020 (K MT)
Table 30. Global Therapeutic Protein Consumption Market Share by Regions 2015-2020
Table 31. Global Therapeutic Protein Value by Regions 2015-2020 ($ Millions)
Table 32. Global Therapeutic Protein Value Market Share by Regions 2015-2020
Table 33. Americas Therapeutic Protein Consumption by Countries (2015-2020) (K MT)
Table 34. Americas Therapeutic Protein Consumption Market Share by Countries (2015-2020)
Table 35. Americas Therapeutic Protein Value by Countries (2015-2020) ($ Millions)
Table 36. Americas Therapeutic Protein Value Market Share by Countries (2015-2020)
Table 37. Americas Therapeutic Protein Consumption by Type (2015-2020) (K MT)
Table 38. Americas Therapeutic Protein Consumption Market Share by Type (2015-2020)
Table 39. Americas Therapeutic Protein Consumption by Application (2015-2020) (K MT)
Table 40. Americas Therapeutic Protein Consumption Market Share by Application (2015-2020)
Table 41. APAC Therapeutic Protein Consumption by Regions (2015-2020) (K MT)
Table 42. APAC Therapeutic Protein Consumption Market Share by Regions (2015-2020)
Table 43. APAC Therapeutic Protein Value by Regions (2015-2020) ($ Millions)
Table 44. APAC Therapeutic Protein Value Market Share by Regions (2015-2020)
Table 45. APAC Therapeutic Protein Consumption by Type (2015-2020) (K MT)
Table 46. APAC Therapeutic Protein Consumption Market Share by Type (2015-2020)
Table 47. APAC Therapeutic Protein Consumption by Application (2015-2020) (K MT)
Table 48. APAC Therapeutic Protein Consumption Market Share by Application (2015-2020)
Table 49. Europe Therapeutic Protein Consumption by Countries (2015-2020) (K MT)
Table 50. Europe Therapeutic Protein Consumption Market Share by Countries (2015-2020)
Table 51. Europe Therapeutic Protein Value by Countries (2015-2020) ($ Millions)
Table 52. Europe Therapeutic Protein Value Market Share by Countries (2015-2020)
Table 53. Europe Therapeutic Protein Consumption by Type (2015-2020) (K MT)
Table 54. Europe Therapeutic Protein Consumption Market Share by Type (2015-2020)
Table 55. Europe Therapeutic Protein Consumption by Application (2015-2020) (K MT)
Table 56. Europe Therapeutic Protein Consumption Market Share by Application (2015-2020)
Table 57. Middle East & Africa Therapeutic Protein Consumption by Countries (2015-2020) (K MT)
Table 58. Middle East & Africa Therapeutic Protein Consumption Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Therapeutic Protein Value by Countries (2015-2020) ($ Millions)
Table 60. Middle East & Africa Therapeutic Protein Value Market Share by Countries (2015-2020)
Table 61. Middle East & Africa Therapeutic Protein Consumption by Type (2015-2020) (K MT)
Table 62. Middle East & Africa Therapeutic Protein Consumption Market Share by Type (2015-2020)
Table 63. Middle East & Africa Therapeutic Protein Consumption by Application (2015-2020) (K MT)
Table 64. Middle East & Africa Therapeutic Protein Consumption Market Share by Application (2015-2020)
Table 65. Therapeutic Protein Distributors List
Table 66. Therapeutic Protein Customer List
Table 67. Global Therapeutic Protein Consumption Forecast by Countries (2021-2025) (K MT)
Table 68. Global Therapeutic Protein Consumption Market Forecast by Regions
Table 69. Global Therapeutic Protein Value Forecast by Countries (2021-2025) ($ Millions)
Table 70. Global Therapeutic Protein Value Market Share Forecast by Regions
Table 71. Global Therapeutic Protein Consumption Forecast by Type (2021-2025) (K MT)
Table 72. Global Therapeutic Protein Consumption Market Share Forecast by Type (2021-2025)
Table 73. Global Therapeutic Protein Value Forecast by Type (2021-2025) ($ Millions)
Table 74. Global Therapeutic Protein Value Market Share Forecast by Type (2021-2025)
Table 75. Global Therapeutic Protein Consumption Forecast by Application (2021-2025) (K MT)
Table 76. Global Therapeutic Protein Consumption Market Share Forecast by Application (2021-2025)
Table 77. Global Therapeutic Protein Value Forecast by Application (2021-2025) ($ Millions)
Table 78. Global Therapeutic Protein Value Market Share Forecast by Application (2021-2025)
Table 79. Amgen Product Offered
Table 80. Amgen Therapeutic Protein Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 81. Amgen Main Business
Table 82. Amgen Latest Developments
Table 83. Amgen Basic Information, Company Total Revenue (in $ million), Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors
Table 84. Generex Biotechnology Product Offered
Table 85. Generex Biotechnology Therapeutic Protein Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 86. Generex Biotechnology Main Business
Table 87. Generex Biotechnology Latest Developments
Table 88. Generex Biotechnology Basic Information, Company Total Revenue (in $ million), Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Laboratories Product Offered
Table 90. Abbott Laboratories Therapeutic Protein Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 91. Abbott Laboratories Main Business
Table 92. Abbott Laboratories Latest Developments
Table 93. Abbott Laboratories Basic Information, Company Total Revenue (in $ million), Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors
Table 94. Baxter International Product Offered
Table 95. Baxter International Therapeutic Protein Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 96. Baxter International Main Business
Table 97. Baxter International Latest Developments
Table 98. Baxter International Basic Information, Company Total Revenue (in $ million), Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors
Table 99. Boehringer Ingelheim Product Offered
Table 100. Boehringer Ingelheim Therapeutic Protein Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 101. Boehringer Ingelheim Main Business
Table 102. Boehringer Ingelheim Latest Developments
Table 103. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors
Table 104. AstraZeneca Product Offered
Table 105. AstraZeneca Therapeutic Protein Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 106. AstraZeneca Main Business
Table 107. AstraZeneca Latest Developments
Table 108. AstraZeneca Basic Information, Company Total Revenue (in $ million), Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors
Table 109. Eli Lilly Product Offered
Table 110. Eli Lilly Basic Information, Company Total Revenue (in $ million), Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors
Table 111. Eli Lilly Main Business
Table 112. Eli Lilly Latest Developments
Table 113. Eli Lilly Therapeutic Protein Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 114. Chugai Pharmaceutical Product Offered
Table 115. Chugai Pharmaceutical Therapeutic Protein Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 116. Chugai Pharmaceutical Main Business
Table 117. Chugai Pharmaceutical Latest Developments
Table 118. Chugai Pharmaceutical Basic Information, Company Total Revenue (in $ million), Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors
Table 119. GeneScience Pharmaceuticals Product Offered
Table 120. GeneScience Pharmaceuticals Therapeutic Protein Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 121. GeneScience Pharmaceuticals Main Business
Table 122. GeneScience Pharmaceuticals Latest Developments
Table 123. GeneScience Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors
Table 124. Diasome Pharmaceuticals Product Offered
Table 125. Diasome Pharmaceuticals Therapeutic Protein Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 126. Diasome Pharmaceuticals Main Business
Table 127. Diasome Pharmaceuticals Latest Developments
Table 128. Diasome Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Therapeutic Protein Manufacturing Base, Sales Area and Its Competitors
Table 129. Genentech Product Offered
Table 130. Genentech Therapeutic Protein Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 131. Genentech Main Business
Table 132. Genentech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Genentech Latest Developments
List of Figures
Figure 1. Picture of Therapeutic Protein
Figure 2. Therapeutic Protein Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Therapeutic Protein Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Therapeutic Protein Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Monoclonal Antibodies
Figure 7. Product Picture of Erythropoietin
Figure 8. Product Picture of Insulin
Figure 9. Product Picture of Interferon
Figure 10. Product Picture of Human Growth Hormone
Figure 11. Product Picture of Follicle Stimulating Hormone
Figure 12. Product Picture of Blood Clotting Factors
Figure 13. Global Therapeutic Protein Consumption Market Share by Type (2015-2020)
Figure 14. Global Therapeutic Protein Value Market Share by Type (2015-2020)
Figure 15. Therapeutic Protein Consumed in Pharmaceutical Companies
Figure 16. Global Therapeutic Protein Market: Pharmaceutical Companies (2015-2020) (K MT)
Figure 17. Global Therapeutic Protein Market: Pharmaceutical Companies (2015-2020) ($ Millions)
Figure 18. Therapeutic Protein Consumed in Healthcare Service Providers
Figure 19. Global Therapeutic Protein Market: Healthcare Service Providers (2015-2020) (K MT)
Figure 20. Global Therapeutic Protein Market: Healthcare Service Providers (2015-2020) ($ Millions)
Figure 21. Therapeutic Protein Consumed in Research Organizations
Figure 22. Global Therapeutic Protein Market: Research Organizations (2015-2020) (K MT)
Figure 23. Global Therapeutic Protein Market: Research Organizations (2015-2020) ($ Millions)
Figure 24. Therapeutic Protein Consumed in Academic Research Institutes
Figure 25. Global Therapeutic Protein Market: Academic Research Institutes (2015-2020) (K MT)
Figure 26. Global Therapeutic Protein Market: Academic Research Institutes (2015-2020) ($ Millions)
Figure 27. Global Therapeutic Protein Consumption Market Share by Application (2015-2020)
Figure 28. Global Therapeutic Protein Value Market Share by Application (2015-2020)
Figure 29. Global Therapeutic Protein Sales Market Share by Company in 2017
Figure 30. Global Therapeutic Protein Sales Market Share by Company in 2019
Figure 31. Global Therapeutic Protein Revenue Market Share by Company in 2017
Figure 32. Global Therapeutic Protein Revenue Market Share by Company in 2019
Figure 33. Global Therapeutic Protein Sale Price by Company in 2019
Figure 34. Global Therapeutic Protein Consumption Market Share by Regions 2015-2020
Figure 35. Global Therapeutic Protein Value Market Share by Regions 2015-2020
Figure 36. Americas Therapeutic Protein Consumption 2015-2020 (K MT)
Figure 37. Americas Therapeutic Protein Value 2015-2020 ($ Millions)
Figure 38. APAC Therapeutic Protein Consumption 2015-2020 (K MT)
Figure 39. APAC Therapeutic Protein Value 2015-2020 ($ Millions)
Figure 40. Europe Therapeutic Protein Consumption 2015-2020 (K MT)
Figure 41. Europe Therapeutic Protein Value 2015-2020 ($ Millions)
Figure 42. Middle East & Africa Therapeutic Protein Consumption 2015-2020 (K MT)
Figure 43. Middle East & Africa Therapeutic Protein Value 2015-2020 ($ Millions)
Figure 44. Americas Therapeutic Protein Consumption Market Share by Countries in 2019
Figure 45. Americas Therapeutic Protein Value Market Share by Countries in 2019
Figure 46. Americas Therapeutic Protein Consumption Market Share by Type in 2019
Figure 47. Americas Therapeutic Protein Consumption Market Share by Application in 2019
Figure 48. United States Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 49. United States Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 50. Canada Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 51. Canada Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 52. Mexico Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 53. Mexico Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 54. APAC Therapeutic Protein Consumption Market Share by Countries in 2019
Figure 55. APAC Therapeutic Protein Value Market Share by Regions in 2019
Figure 56. APAC Therapeutic Protein Consumption Market Share by Type in 2019
Figure 57. APAC Therapeutic Protein Consumption Market Share by Application in 2019
Figure 58. China Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 59. China Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 60. Japan Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 61. Japan Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 62. Korea Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 63. Korea Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 64. Southeast Asia Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 65. Southeast Asia Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 66. India Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 67. India Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 68. Australia Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 69. Australia Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 70. Europe Therapeutic Protein Consumption Market Share by Countries in 2019
Figure 71. Europe Therapeutic Protein Value Market Share by Countries in 2019
Figure 72. Europe Therapeutic Protein Consumption Market Share by Type in 2019
Figure 73. Europe Therapeutic Protein Consumption Market Share by Application in 2019
Figure 74. Germany Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 75. Germany Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 76. France Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 77. France Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 78. UK Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 79. UK Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 80. Italy Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 81. Italy Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 82. Russia Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 83. Russia Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 84. Middle East & Africa Therapeutic Protein Consumption Market Share by Countries in 2019
Figure 85. Middle East & Africa Therapeutic Protein Value Market Share by Countries in 2019
Figure 86. Middle East & Africa Therapeutic Protein Consumption Market Share by Type in 2019
Figure 87. Middle East & Africa Therapeutic Protein Consumption Market Share by Application in 2019
Figure 88. Egypt Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 89. Egypt Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 90. South Africa Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 91. South Africa Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 92. Israel Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 93. Israel Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 94. Turkey Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 95. Turkey Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 96. GCC Countries Therapeutic Protein Consumption Growth 2015-2020 (K MT)
Figure 97. GCC Countries Therapeutic Protein Value Growth 2015-2020 ($ Millions)
Figure 98. Global Therapeutic Protein Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 99. Global Therapeutic Protein Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 100. Americas Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 101. Americas Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 102. APAC Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 103. APAC Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 104. Europe Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 105. Europe Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 106. Middle East & Africa Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 107. Middle East & Africa Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 108. United States Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 109. United States Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 110. Canada Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 111. Canada Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 112. Mexico Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 113. Mexico Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 114. Brazil Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 115. Brazil Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 116. China Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 117. China Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 118. Japan Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 119. Japan Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 120. Korea Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 121. Korea Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 122. Southeast Asia Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 123. Southeast Asia Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 124. India Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 125. India Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 126. Australia Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 127. Australia Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 128. Germany Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 129. Germany Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 130. France Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 131. France Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 132. UK Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 133. UK Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 134. Italy Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 135. Italy Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 136. Russia Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 137. Russia Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 138. Spain Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 139. Spain Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 140. Egypt Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 141. Egypt Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 142. South Africa Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 143. South Africa Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 144. Israel Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 145. Israel Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 146. Turkey Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 147. Turkey Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 148. GCC Countries Therapeutic Protein Consumption 2021-2025 (K MT)
Figure 149. GCC Countries Therapeutic Protein Value 2021-2025 ($ Millions)
Figure 150. Amgen Therapeutic Protein Market Share (2018-2020)
Figure 151. Generex Biotechnology Therapeutic Protein Market Share (2018-2020)
Figure 152. Abbott Laboratories Therapeutic Protein Market Share (2018-2020)
Figure 153. Baxter International Therapeutic Protein Market Share (2018-2020)
Figure 154. Boehringer Ingelheim Therapeutic Protein Market Share (2018-2020)
Figure 155. AstraZeneca Therapeutic Protein Market Share (2018-2020)
Figure 156. Eli Lilly Therapeutic Protein Market Share (2018-2020)
Figure 157. Chugai Pharmaceutical Therapeutic Protein Market Share (2018-2020)
Figure 158. GeneScience Pharmaceuticals Therapeutic Protein Market Share (2018-2020)
Figure 159. Diasome Pharmaceuticals Therapeutic Protein Market Share (2018-2020)
Figure 160. Genentech Therapeutic Protein Market Share (2018-2020)
Reason to Buy